Stay updated on Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error instead of study details, alongside a general NIH announcement about its terminology transition.
    Difference
    2%
    Check dated 2026-10-24T18:59:57.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T19:00:17.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T19:40:50.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study details content with an access-denied message.
    Difference
    0.5%
    Check dated 2026-09-26T20:12:56.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added, and multiple items under Study Documents were removed (including the Study Protocol and Statistical Analysis Plan and associated metadata), reducing access to core study materials.
    Difference
    21%
    Check dated 2026-09-19T20:15:24.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page’s revision tag changed from v3.6.5 to v3.6.6, indicating a new published version of the page. This update reflects a version bump and does not modify the study content or data presented.
    Difference
    0.1%
    Check dated 2026-08-29T19:57:03.000Z thumbnail image

Stay in the know with updates to Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cediranib+Olaparib vs Other Treatments in Ovarian Cancer Clinical Trial page.